Skip to main content
RWAY
NASDAQ Unknown

Runway Growth Finance Completes Transformational $249M Acquisition of SWK Holdings, Issues 6.3M Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Credit Services Stocks · Financial
Sentiment info
Positive
Importance info
9
Price
$6.969
Mkt Cap
$249.686M
52W Low
$6.58
52W High
$11.405
52W Position info
5.9% above low
Off High info
39% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

RWAY is trading near its 52-week low of $6.58 (5.9% above the low).

Summary

Runway Growth Finance Corp. has completed its previously announced $249 million acquisition of SWK Holdings Corporation, significantly expanding its balance sheet and increasing its exposure to healthcare and life sciences investments.


Key Events · M&A and Partnerships · RWAY

  • Acquisition of SWK Holdings Completed

    Runway Growth Finance Corp. completed its previously announced acquisition of SWK Holdings Corporation for $249.0 million, effective April 6, 2026. This follows the prospectus supplement filed on March 24, 2026, detailing the finalized terms.

  • Significant Share Issuance and Dilution

    The company issued approximately 6,330,640 shares of common stock to former SWK stockholders as part of the merger consideration.

  • Balance Sheet Expansion and Strategic Shift

    The acquisition expands Runway Growth's balance sheet to $1.2 billion in total assets on a pro forma basis and increases healthcare and life sciences investments to approximately 32% of the portfolio, from 14%.

  • Assumption of SWK Debt

    Runway Growth assumed $30 million in aggregate principal amount of SWK's 9.00% Senior Notes due 2027 as part of the merger.


Analysis · RWAY · Unknown

This 8-K announces the completion of a major strategic acquisition that was previously disclosed. The $249 million transaction, which includes the issuance of approximately 6.33 million shares and $173.5 million in cash, nearly doubles the company's total assets to $1.2 billion on a pro forma basis. Management expects the acquisition to be accretive to net investment income, enhance earnings power, and support dividend coverage. The deal also diversifies the portfolio, increasing healthcare and life sciences investments from 14% to 32%. Investors should monitor the integration process and the actual financial impact on net investment income and dividend coverage in upcoming earnings reports.

At the time of this filing, RWAY was trading at $6.97 on NASDAQ in the Unknown sector, with a market capitalization of approximately $249.7M. The 52-week trading range was $6.58 to $11.41. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RWAY - Latest Insights

RWAY
Jul 15, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.62
Real-time Price: $5.50 info
Change: -$0.120 (-2%) info
Market Cap: $227.398M info
RWAY
Jul 14, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.31
Real-time Price: $5.50 info
Change: +$0.190 (+4%) info
Market Cap: $227.398M info
RWAY
Jul 06, 2026, 1:49 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.64
Real-time Price: $5.50 info
Change: -$0.140 (-2%) info
Market Cap: $227.398M info
RWAY
May 29, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.47
Real-time Price: $5.50 info
Change: -$0.970 (-15%) info
Market Cap: $227.398M info
RWAY
May 28, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $6.53
Real-time Price: $5.50 info
Change: -$1.03 (-16%) info
Market Cap: $227.398M info